Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature. Cardiovasc Revasc Med 2018;19(7 Pt B):874-878

Date

04/11/2018

Pubmed ID

29636301

DOI

10.1016/j.carrev.2018.02.011

Scopus ID

2-s2.0-85044930907 (requires institutional sign-in at Scopus site)   3 Citations

Abstract

Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.

Author List

Rufian-Andujar S, Iftikhar O, Salinger M, Saucedo J, Feldman T, Guerrero M

Author

Jorge Saucedo MD Chief, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Administration, Intravenous
Aged, 80 and over
Bioprosthesis
Cardiac Catheterization
Cardiotonic Agents
Echocardiography, Doppler, Color
Echocardiography, Transesophageal
Female
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
Hemodynamics
Humans
Intra-Aortic Balloon Pumping
Mitral Valve
Mitral Valve Insufficiency
Prosthesis Design
Prosthesis Failure
Recovery of Function
Recurrence
Shock, Cardiogenic
Treatment Outcome